Publication:
Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe?

Simple item page
dc.contributor.authorShilpa R. Jainen_US
dc.contributor.authorPakpoom Phoompoungen_US
dc.contributor.authorShahid Husainen_US
dc.contributor.otherUniversity Health Network University of Torontoen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2020-01-27T09:21:15Z
dc.date.available2020-01-27T09:21:15Z
dc.date.issued2019-11-27en_US
dc.identifier.citationClinical Infectious Diseases. Vol.69, No.12 (2019), 2234-2235en_US
dc.identifier.doi10.1093/cid/ciz376en_US
dc.identifier.issn15376591en_US
dc.identifier.issn10584838en_US
dc.identifier.other2-s2.0-85075805521en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/51299
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075805521&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleIs Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe?en_US
dc.typeLetteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075805521&origin=inwarden_US

Files

Collections

Scopus 2019